NCT07904169Not yet recruiting
A Speaking-Valve-Based Decannulation Protocol for Tracheostomized Stroke Patients
Application of a Speaking-Valve-Based Decannulation Protocol in Tracheostomized Stroke Patients: A Prospective Multicenter Cohort Study
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
To evaluate the feasibility of a speaking-valve-based decannulation protocol in tracheostomized stroke patients
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 207 (estimated)
- First submitted
- 15 Oct 2026
- Start date
- 1 Nov 2026
- Primary completion date
- 1 Nov 2027
- Lead sponsor
- Hongying Jiang, MD
- Diseases
- Stroke
- NCT number
- NCT07904169
What you commit to
- Study type: Observational
- Planned participants: 207
- From 1 Nov 2026 to the primary completion date, 1 Nov 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of severe, uncontrolled neurological disorders or other systemic diseases (e.g., advanced cancer, severe heart failure).
Other
- Expected survival time \<2 weeks, or planned transfer to another non-cooperative healthcare facility within 2 weeks;
Who the study is looking for
- Tracheostomy performed following stroke (ischemic or hemorrhagic);
- Stable phase of stroke: clinically defined as the intermediate-to-late recovery phase plus the sequelae phase, during which the patient exhibits stable vital signs, resolution of cerebral edema, normalization of intracranial pressure, and absence of new neurological deficits (e.g., no recurrence of hemiplegia or aphasia), thereby entering a phase focused primarily on rehabilitation and secondary prevention.
- Written informed consent has been obtained and approved by the Institutional Review Board (IRB).
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.